| P2093 | author name string | Xin Wei Wang | |
| | Taro Yamashita | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth | Q24296787 |
| | Nuclear signalling by tumour-associated antigen EpCAM | Q24315870 |
| | Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma | Q24609544 |
| | A decade of exploring the cancer epigenome - biological and translational implications | Q24614467 |
| | Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 |
| | MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 |
| | The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 |
| | Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells | Q24656933 |
| | Tumor self-seeding by circulating cancer cells | Q24658224 |
| | The stem cell niche in regenerative medicine | Q26827224 |
| | Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes | Q27478288 |
| | Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog | Q27487860 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| | Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 |
| | A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 |
| | Clonal origin of human tumors | Q28144871 |
| | The stem-cell niche as an entity of action | Q28249490 |
| | Immortalization eliminates a roadblock during cellular reprogramming into iPS cells | Q28254388 |
| | Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma | Q28257545 |
| | Management of HCC | Q28258769 |
| | Significance of CD90+ cancer stem cells in human liver cancer | Q28266933 |
| | Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells | Q39976254 |
| | EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma | Q40006245 |
| | Identification of local and circulating cancer stem cells in human liver cancer | Q40013131 |
| | CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. | Q40076996 |
| | Identification and characterization of tumorigenic liver cancer stem/progenitor cells | Q40119609 |
| | Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties | Q40262786 |
| | Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm | Q40424240 |
| | Cytokines and cellular crosstalk involved in the activation of fat-storing cells | Q40477129 |
| | Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification | Q40679546 |
| | mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis | Q41910369 |
| | Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis | Q42991520 |
| | Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle | Q43047407 |
| | Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis. | Q44410161 |
| | Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection | Q44421418 |
| | Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection | Q45212238 |
| | Mesodermal Wnt2b signalling positively regulates liver specification. | Q45995605 |
| | A CD133-expressing murine liver oval cell population with bilineage potential | Q46285754 |
| | Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin | Q46661060 |
| | Identification of adult hepatic progenitor cells capable of repopulating injured rat liver | Q46893464 |
| | Wnt/beta-catenin signaling mediates oval cell response in rodents | Q46955919 |
| | Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways | Q47624575 |
| | A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells | Q50115050 |
| | Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. | Q51890946 |
| | Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. | Q52580893 |
| | Transforming the microenvironment: a trick of the metastatic cancer cell. | Q53264547 |
| | Coexpression of stemness factors Oct4 and Nanog predict liver resection. | Q53272128 |
| | Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. | Q53325259 |
| | Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. | Q53326694 |
| | Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. | Q53343023 |
| | Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. | Q53449416 |
| | Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration. | Q53720354 |
| | Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. | Q54490308 |
| | BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma. | Q54498797 |
| | Hepatic progenitor cells from adult human livers for cell transplantation. | Q54536885 |
| | Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. | Q54697660 |
| | Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment | Q60675548 |
| | Purification of Fetal Liver Stem/Progenitor Cells Containing all the Repopulation Potential for Normal Adult Rat Liver | Q61822603 |
| | Liver regeneration | Q63664803 |
| | Metastasis results from preexisting variant cells within a malignant tumor | Q67602509 |
| | Isolation of hepatoblasts based on the expression of Dlk/Pref-1 | Q73193231 |
| | Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium | Q73400327 |
| | Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats | Q74127872 |
| | Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver | Q74127878 |
| | Molecular pathogenesis of human hepatocellular carcinoma | Q74543031 |
| | Purification of fetal mouse hepatoblasts by magnetic beads coated with monoclonal anti-e-cadherin antibodies and their in vitro culture | Q74816460 |
| | Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man | Q77386873 |
| | Initiation of mammalian liver development from endoderm by fibroblast growth factors | Q77894646 |
| | Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells | Q77906218 |
| | Cancer stem cells | Q80312237 |
| | Comparison of hepatic properties and transplantation of Thy-1(+) and Thy-1(-) cells isolated from embryonic day 14 rat fetal liver | Q80658579 |
| | Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis | Q82299264 |
| | Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands | Q83288851 |
| | CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma | Q84059678 |
| | High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma | Q84155878 |
| | Prospective isolation and characterization of bipotent progenitor cells in early mouse liver development | Q84810989 |
| | Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators | Q28267500 |
| | The clonal evolution of tumor cell populations | Q28271546 |
| | Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors | Q28585487 |
| | Liver fibrosis | Q29547449 |
| | A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity | Q29614209 |
| | Hepatocellular carcinoma pathogenesis: from genes to environment | Q29615767 |
| | Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells | Q29617991 |
| | Suppression of induced pluripotent stem cell generation by the p53-p21 pathway | Q29619160 |
| | Friends or foes - bipolar effects of the tumour stroma in cancer | Q29619348 |
| | Cells of origin in cancer | Q29619557 |
| | Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein | Q29620682 |
| | EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features | Q30493364 |
| | CD13 is a therapeutic target in human liver cancer stem cells | Q30496324 |
| | Stem cells, cell transplantation and liver repopulation | Q33801245 |
| | Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta | Q33820694 |
| | Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers | Q33949936 |
| | Liver stem cells and their implication in hepatocellular and cholangiocarcinoma | Q33997118 |
| | Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state | Q34178901 |
| | Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells | Q34233172 |
| | Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | Q34235518 |
| | Canals of Hering: recent insights and current knowledge | Q34313747 |
| | Clinical implications of cancer stem cell biology in hepatocellular carcinoma | Q34357073 |
| | Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer | Q34377430 |
| | Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver | Q34402328 |
| | Cancer stem cells: an old idea--a paradigm shift | Q34495973 |
| | Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion | Q34545548 |
| | Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. | Q34672668 |
| | Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages | Q34773026 |
| | Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. | Q34798776 |
| | Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? | Q34988085 |
| | Cytokine regulation of liver development | Q34991828 |
| | Cellular origin of hepatocellular carcinomas | Q35018040 |
| | Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3 | Q35101216 |
| | Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. | Q35237526 |
| | Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming | Q35312062 |
| | Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts | Q35531664 |
| | CD24-positive cells from normal adult mouse liver are hepatocyte progenitor cells | Q35575805 |
| | Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss | Q35613285 |
| | Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury | Q35677684 |
| | Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture | Q35713428 |
| | Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes | Q35764088 |
| | Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. | Q35823178 |
| | Cancer stem cells: impact, heterogeneity, and uncertainty | Q35857599 |
| | Liver development update: new embryo models, cell lineage control, and morphogenesis | Q35893556 |
| | Neuroregulation of the neuroendocrine compartment of the liver | Q35894484 |
| | Cholangiocarcinomas can originate from hepatocytes in mice | Q36129118 |
| | Human hepatic stem cells from fetal and postnatal donors | Q36229597 |
| | TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. | Q36237549 |
| | Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression | Q36248716 |
| | Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma | Q36279142 |
| | Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice | Q36421780 |
| | Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling | Q36497297 |
| | Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma | Q36547263 |
| | Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis | Q36692164 |
| | TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer | Q36777331 |
| | WNT/beta-catenin signaling in liver health and disease | Q36804161 |
| | Liver cancer stem cells | Q36835025 |
| | Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium | Q37041709 |
| | Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma | Q37284612 |
| | Liver stem cells and hepatocellular carcinoma | Q37358938 |
| | The role of signaling pathways in the development and treatment of hepatocellular carcinoma | Q37773788 |
| | Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma | Q39240497 |
| | OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma | Q39345207 |
| | DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma | Q39413382 |
| | CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling | Q39459026 |
| | CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation | Q39512947 |
| | Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. | Q39581200 |
| | Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. | Q39592731 |
| | miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. | Q39626637 |
| | Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation | Q39639351 |
| | Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation | Q39702464 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cancer | Q623031 |
| | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 1911-1918 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Cancer stem cells in the development of liver cancer | |
| P478 | volume | 123 | |